Authors: HARTMANN A EIDE TC FAUCHALD P BENTDAL O HERBERT J GALLIMORE JR PEPYS MB

Citation: A. Hartmann et al., SERUM AMYLOID-A PROTEIN IS A CLINICALLY USEFUL INDICATOR OF ACUTE RENAL-ALLOGRAFT REJECTION, Nephrology, dialysis, transplantation, 12(1), 1997, pp. 161-166

Authors: HARTMANN A EIDE TC FAUCHALD P BENTDAL O HERBERT J GALLIMORE JR PEPYS MB

Citation: A. Hartmann et al., SERUM AMYLOID A PROTEIN IS A CLINICALLY USEFUL INDICATOR OF ACUTE RENAL-ALLOGRAFT REJECTION, Journal of the American Society of Nephrology, 7(9), 1996, pp. 3320-3320

Authors: MIDTVEDT K TAFJORD AB NORDAL KP DRAGANOV B EIDE TC HARTMAN A BERG KJ HOLDAAS H FAUCHALD P

Citation: K. Midtvedt et al., OKT3 IN STEROID-RESISTANT REJECTIONS IN RENAL-TRANSPLANT RECIPIENTS -2.5 MG VS 5.0 MG, Kidney international, 49(3), 1996, pp. 921-921

Authors: HOLDAAS H DAHL K HARTMANN A STENSTROM J AASAROD K DRAGANOV B LUND K NORDAL K BERG KJ BORGE M EIDE TC FAUCHALD P

Citation: H. Holdaas et al., FLUVASTATIN LOWERS ATHEROGENIC LIPIDS SAFELY IN RENAL TRANSPLANTED PATIENTS, Kidney international, 49(3), 1996, pp. 927-927

Authors: MIDTVEDT K TAFJORD AB HARTMANN A EIDE TC HOLDAAS H NORDAL KP DRAGANOV B SODAL G LEIVESTAD T FAUCHALD P

Citation: K. Midtvedt et al., HALF DOSE OF OKT3 IS EFFICIENT IN TREATMENT OF STEROID-RESISTANT RENAL-ALLOGRAFT REJECTION, Transplantation, 62(1), 1996, pp. 38-42